RESOLUTE INTEGRITY RX
Report
- Report Number
- 9612164-2015-01208
- Event Type
- Death
- Date Received
- July 6, 2015
- Date of Event
- December 7, 2013
- Report Date
- October 6, 2015
- Manufacturer
- MEDTRONIC IRELAND
- Product Code
- NIQ
- PMA / PMN Number
- P110013
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- JA
- Reporter Occupation
- OTHER
Narratives
EVALUATION CODES, RESULTS: INHERENT RISK OF PROCEDURE ¿ (CVA/STROKE,DEATH) EVALUATION CODES, CONCLUSIONS: INHERENT RISK OF PROCEDURE (B)(4).
THE PATIENT HAD A HISTORY OF HYPERTENSION, HYPERLIPIDEMIA, DIABETES AND PREVIOUS PCI. INDEX PROCEDURE WAS PROMPTED BY STABLE ANGINA. DURING THE INDEX PROCEDURE THE 3 RSINT STENTS WERE IMPLANTED IN THE FOLLOWING VESSELS, 2 IN THE CX AND THE 3RD IN THE 2ND OM. DURING A STAGED PROCEDURE APPROX. 1 MONTH LATER ANOTHER 4 RESOLUTE INTEGRITY DRUG-ELUTING STENTS WERE IMPLANTED IN THE RCA. IT WAS ASSESSED THAT THE STROKE AND CARDIAC DEATH WERE NOT RELATED TO THE STUDY STENTS.
CEC HAS ADJUDICATED THE PREVIOUSLY REPORTED DEATH WAS NOT RELATED TO THE STUDY DEVICE.
THREE RESOLUTE INTEGRITY DRUG-ELUTING STENTS WERE IMPLANTED; ONE IN THE 2ND DIAGONAL, LCX AND 2ND OM DURING THE INDEX PROCEDURE. APPROXIMATELY 4 DAYS POST INDEX PROCEDURE PATIENT SUFFERED CEREBROVASCULAR DISORDER PATIENT WAS HOSPITALISED FOR TREATMENT. APPROXIMATELY 3 MONTHS POST INDEX PROCEDURE PATIENT EXPIRED. CAUSE OF DEATH WAS CARDIAC DEATH.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 437400 | RESOLUTE INTEGRITY RX | STENT, CORONARY, DRUG-ELUTING | NIQ | MEDTRONIC IRELAND |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 00076 YR | Death| H |